Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,105,671 articles, preprints and more)

Search results

1-25 of 223 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.
Kurz SC, Stammberger A, Rosahl SK, Abrey LE, Albert NL, von Baumgarten L, Gempt J, Grosu AL, Leidgens V, McLean A, Renovanz M, Schwarzenberger J, Sevenich L, Urbanic Purkart T, Combs SE, Tabatabai G, Hegi M, Nowosielski M
Neuro Oncol, 25(12):2302-2304, 01 Dec 2023
Cited by: 0 articles | PMID: 37738478 | PMCID: PMC10708925
Add to export list Free full text in Europe PMC
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma.
Ellingson BM, Hagiwara A, Morris CJ, Cho NS, Oshima S, Sanvito F, Oughourlian TC, Telesca D, Raymond C, Abrey LE, Garcia J, Aftab DT, Hessel C, Rachmilewitz Minei T, Harats D, Nathanson DA, Wen PY, Cloughesy TF
Clin Cancer Res, 29(20):4186-4195, 01 Oct 2023
Cited by: 0 articles | PMID: 37540556
Add to export list
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T
J Clin Oncol, 41(32):4945-4952, 01 Nov 2023
Cited by: 4 articles | PMID: 37935104
Add to export list
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
Hagiwara A, Schlossman J, Shabani S, Raymond C, Tatekawa H, Abrey LE, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Cloughesy TF, Ellingson BM
J Neurooncol, 159(3):509-518, 17 Jul 2022
Cited by: 6 articles | PMID: 35842871
Add to export list
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Rahman R, Ventz S, McDunn J, Louv B, Reyes-Rivera I, Polley MC, Merchant F, Abrey LE, Allen JE, Aguilar LK, Aguilar-Cordova E, Arons D, Tanner K, Bagley S, Khasraw M, Cloughesy T, Wen PY, Alexander BM, Trippa L
Lancet Oncol, 22(10):e456-e465, 01 Oct 2021
Cited by: 39 articles | PMID: 34592195 | PMCID: PMC8893120
Add to export list Review Free full text in Europe PMC
Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma.
Kaley TJ, Panageas KS, Pentsova EI, Mellinghoff IK, Nolan C, Gavrilovic I, DeAngelis LM, Abrey LE, Holland EC, Omuro A, Lacouture ME, Ludwig E, Lassman AB
Ann Clin Transl Neurol, 7(4):429-436, 15 Apr 2020
Cited by: 23 articles | PMID: 32293798 | PMCID: PMC7187704
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.
Chen H, Kuhn J, Lamborn KR, Abrey LE, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WKA, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Wen PY, Gilbert MR
Neurooncol Adv, 2(1):vdaa124, 01 Jan 2020
Cited by: 7 articles | PMID: 33235994 | PMCID: PMC7668489
Add to export list Free full text in Europe PMC
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
Correa DD, Braun E, Kryza-Lacombe M, Ho KW, Reiner AS, Panageas KS, Yahalom J, Sauter CS, Abrey LE, DeAngelis LM, Omuro A
J Neurooncol, 144(3):553-562, 03 Aug 2019
Cited by: 30 articles | PMID: 31377920 | PMCID: PMC7392129
Add to export list Free full text in Europe PMC
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.
Kaley TJ, Panageas KS, Mellinghoff IK, Nolan C, Gavrilovic IT, DeAngelis LM, Abrey LE, Holland EC, Lassman AB
J Neurooncol, 144(2):403-407, 19 Jul 2019
Cited by: 37 articles | PMID: 31325145 | PMCID: PMC7493746
Add to export list Free full text in Europe PMC
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.
Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, [...] Cloughesy TF
Neuro Oncol, 20(9):1240-1250, 01 Aug 2018
Cited by: 44 articles | PMID: 29660006 | PMCID: PMC6071654
Add to export list Free full text in Europe PMC
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
Ellingson BM, Abrey LE, Garcia J, Chinot O, Wick W, Saran F, Nishikawa R, Henriksson R, Mason WP, Harris RJ, Leu K, Woodworth DC, Mehta A, Raymond C, Chakhoyan A, Pope WB, Cloughesy TF
Neuro Oncol, 20(11):1525-1535, 01 Oct 2018
Cited by: 8 articles | PMID: 29897562 | PMCID: PMC6178278
Add to export list Free full text in Europe PMC
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.
Wirsching HG, Tabatabai G, Roelcke U, Hottinger AF, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Caparrotti F, von Moos R, Riklin C, Felsberg J, Roth P, Jones DTW, Pfister S, [...] Weller M
Ann Oncol, 29(6):1423-1430, 01 Jun 2018
Cited by: 34 articles | PMID: 29648580
Add to export list
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.
Grill J, Massimino M, Bouffet E, Azizi AA, McCowage G, Cañete A, Saran F, Le Deley MC, Varlet P, Morgan PS, Jaspan T, Jones C, Giangaspero F, Smith H, Garcia J, Elze MC, Rousseau RF, Abrey L, Hargrave D, Vassal G
J Clin Oncol, 36(10):951-958, 07 Feb 2018
Cited by: 64 articles | PMID: 29412784
Add to export list
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States.
Davies J, Reyes-Rivera I, Pattipaka T, Skirboll S, Ugiliweneza B, Woo S, Boakye M, Abrey L, Garcia J, Burton E
Neurooncol Pract, 5(4):251-261, 06 Feb 2018
Cited by: 9 articles | PMID: 31385957 | PMCID: PMC6655482
Add to export list Free full text in Europe PMC
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio.
Nowosielski M, Ellingson BM, Chinot OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP, Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T, Abrey LE, Cloughesy TF, Bendszus M, Wick W
Neuro Oncol, 20(4):557-566, 01 Mar 2018
Cited by: 17 articles | PMID: 29016943 | PMCID: PMC5909665
Add to export list Free full text in Europe PMC
NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS
Ellingson B, Abrey L, Nelson S, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason W, Wick W, Butowski N, Ligon K, Gerstner E, Colman H, de Groot J, Chang S, Mellinghoff I, Young R, Colen R, [...] Cloughesy T
Neuro Oncol, 19(suppl 6):vi154-vi154, 01 Nov 2017
Cited by: 0 articles | PMCID: PMC5692758
Add to export list Free full text in Europe PMC
NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS
Ellingson B, Abrey L, Nelson S, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason W, Wick W, Butowski N, Ligon K, Gerstner E, Colman H, Taylor J, Arrillaga-Romany I, Huang R, Pope W, Reardon D, [...] Cloughesy T
Neuro Oncol, 19(suppl 6):vi161-vi161, 01 Nov 2017
Cited by: 0 articles | PMCID: PMC5692354
Add to export list Free full text in Europe PMC
CNS Anticancer Drug Discovery and Development: 2016 conference insights.
Levin VA, Abrey LE, Heffron TP, Tonge PJ, Dar AC, Weiss WA, Gallo JM
CNS Oncol, 6(3):167-177, 18 Jul 2017
Cited by: 8 articles | PMID: 28718326 | PMCID: PMC6009211
Add to export list Free full text in Europe PMC
ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Weller M, Tabatabai G, Roelcke U, Hottinger A, Joerger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Caparrotti F, von Moos R, Riklin C, Felsberg J, Roth P, Jones D, Pfister S, [...] Wirsching H
Neuro Oncol, 19(suppl 6):vi2-vi2, 01 Nov 2017
Cited by: 0 articles | PMCID: PMC5692456
Add to export list Free full text in Europe PMC
NIMG-01. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM ANTI-VEGF MONOTHERAPY IN GLIOBLASTOMA AT FIRST OR SECOND RELAPSE
Ellingson B, Gerstner E, Smits M, Huang R, Colen R, Abrey L, Aftab D, Schwab G, Hessel C, Gahrmann R, Pope W, de Groot J, Wen P, Batchelor T, van den Bent M, Cloughesy T
Neuro Oncol, 19(suppl 6):vi142-vi143, 01 Nov 2017
Cited by: 0 articles | PMCID: PMC5692227
Add to export list Free full text in Europe PMC
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.
Grossmann P, Narayan V, Chang K, Rahman R, Abrey L, Reardon DA, Schwartz LH, Wen PY, Alexander BM, Huang R, Aerts HJWL
Neuro Oncol, 19(12):1688-1697, 01 Nov 2017
Cited by: 57 articles | PMID: 28499022 | PMCID: PMC5716072
Add to export list Free full text in Europe PMC
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
Nghiemphu PL, Ebiana VA, Wen P, Gilbert M, Abrey LE, Lieberman F, DeAngelis LM, Robins HI, Yung WKA, Chang S, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados M, Kuhn J, Cloughesy TF
J Neurooncol, 136(1):79-86, 07 Oct 2017
Cited by: 17 articles | PMID: 28988377 | PMCID: PMC5756101
Add to export list Free full text in Europe PMC
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.
Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, [...] Omuro A
Neuro Oncol, 19(10):1380-1390, 01 Oct 2017
Cited by: 18 articles | PMID: 28472509 | PMCID: PMC5596171
Add to export list Free full text in Europe PMC
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.
Ellingson BM, Gerstner ER, Smits M, Huang RY, Colen R, Abrey LE, Aftab DT, Schwab GM, Hessel C, Harris RJ, Chakhoyan A, Gahrmann R, Pope WB, Leu K, Raymond C, Woodworth DC, de Groot J, Wen PY, Batchelor TT, [...] Cloughesy TF
Clin Cancer Res, 23(19):5745-5756, 27 Jun 2017
Cited by: 33 articles | PMID: 28655794 | PMCID: PMC5626594
Add to export list Free full text in Europe PMC
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.
Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF
Neuro Oncol, 19(1):89-98, 31 Aug 2016
Cited by: 53 articles | PMID: 27580889 | PMCID: PMC5193027
Add to export list Free full text in Europe PMC

1-25 of 223 results

1 2 3 Next ...

Search life-sciences literature (45,105,671 articles, preprints and more)

Search results

Partnerships & funding